Search Count: 25
All
Selected
 |
Organism: Human coronavirus hku1
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2026-05-06 Classification: VIRAL PROTEIN Ligands: A1CHF |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2026-05-06 Classification: VIRAL PROTEIN Ligands: A1CHJ, PO4 |
 |
Organism: Human coronavirus 229e
Method: X-RAY DIFFRACTION Resolution:1.32 Å Release Date: 2026-05-06 Classification: VIRAL PROTEIN Ligands: A1CHJ, 12P |
 |
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2026-05-06 Classification: VIRAL PROTEIN Ligands: A1CHJ |
 |
Organism: Infectious bronchitis virus
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2026-05-06 Classification: VIRAL PROTEIN Ligands: A1CHJ |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2026-02-11 Classification: VIRAL PROTEIN Ligands: A1CHF, PO4 |
 |
Organism: Human coronavirus 229e
Method: X-RAY DIFFRACTION Resolution:1.41 Å Release Date: 2026-02-11 Classification: VIRAL PROTEIN Ligands: A1CHF, 12P |
 |
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:2.28 Å Release Date: 2026-02-11 Classification: VIRAL PROTEIN Ligands: A1CHF |
 |
Organism: Infectious bronchitis virus
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2026-02-11 Classification: VIRAL PROTEIN Ligands: A1CHF |
 |
Organism: Human coronavirus oc43
Method: X-RAY DIFFRACTION Resolution:2.31 Å Release Date: 2026-02-11 Classification: VIRAL PROTEIN Ligands: A1CHF |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2025-07-16 Classification: VIRAL PROTEIN Ligands: A1IUN, EDO |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.28 Å Release Date: 2025-07-16 Classification: VIRAL PROTEIN Ligands: A1IUM, EDO |
 |
Human Thyroid Hormone Receptor Beta Ligand Binding Domain In Complex With Beta-Selective Agonist Alg-055009
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.88 Å Release Date: 2024-09-11 Classification: MEMBRANE PROTEIN Ligands: A1H2J |
 |
Human Thyroid Hormone Receptor Alpha Ligand Binding Domain In Complex With Beta-Selective Agonist Alg-055009
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.74 Å Release Date: 2024-09-11 Classification: MEMBRANE PROTEIN Ligands: A1H2J, SO4 |
 |
Organism: Enterococcus faecalis
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2020-05-13 Classification: UNKNOWN FUNCTION Ligands: CA |
 |
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:3.75 Å Release Date: 2019-07-10 Classification: SIGNALING PROTEIN Ligands: ZN |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2019-07-10 Classification: SIGNALING PROTEIN Ligands: ZN |
 |
X-Ray Crystal Structure Of Ns3 Helicase From Hcv With A Bound Fragment Inhibitor At 2.08 A Resolution
Organism: Hepatitis c virus
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2015-12-23 Classification: HYDROLASE/HYDROLASE INHIBITOR |
 |
X-Ray Crystal Structure Of Ns3 Helicase From Hcv With A Bound Inhibitor At 2.42 A Resolution
Organism: Hepatitis c virus
Method: X-RAY DIFFRACTION Resolution:2.42 Å Release Date: 2015-12-23 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 3VZ |
 |
Crystal Structure Of Proteinase K From Engyodontium Albuminhibited By Methoxysuccinyl-Ala-Ala-Pro-Phe-Chloromethyl Ketone At 1.15 A Resolution
Organism: Engyodontium album, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.15 Å Release Date: 2015-05-06 Classification: hydrolase/hydrolase inhibitor Ligands: CA |